Efficacy and Safety Study of Dupilumab in Patients with Persistent Asthma - Trial 2022-002375-11
Access comprehensive clinical trial information for 2022-002375-11 through Pure Global AI's free database. This phase not specified trial is sponsored by Sanofi-aventis recherche & développement and is currently status unknown. The study focuses on Asthma.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to EU Clinical Trials Register data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Sanofi-aventis recherche & développement
Timeline & Enrollment
N/A
N/A
N/A
Primary Outcome
-Patients <12 years of age or the minimum legal age for adolescents in the country of the investigative site, whichever is higher (for those countries where local regulations permit enrollment of adults only, patient recruitment will be restricted to those who are ≥18 years of age).
ICD-10 Classifications
Data Source
EU Clinical Trials Register
2022-002375-11
Non-Device Trial